David Shannon Treatt CEO

Treatt CEO David Shannon will depart on 31 December, after a takeover bid he recommended was rejected by shareholders

Flavourings and scents maker Treatt has reshuffled its leadership following CEO David Shannon’s resignation in late November 2025.

Newcomer Manprit Randhawa, who joined Treatt in September as interim CFO, will step up as interim group managing director on 1 January, with group finance director and investor relations lead Kelly Gordon taking on responsibility for the group’s finance and reporting functions.

Shannon, who will depart on 31 December, stepped down in November after shareholders rejected a takeover bid from flavour manufacturer Natara Global that he had recommended.

Opposition to the deal was led by fellow ingredients group Döhler, which built a 28% stake in Treatt after the planned sale was made public.

Treatt chairman Vijay Thakrar said the board was “delighted” both Randhawa and Gordon had accepted additional responsibilities.

“Manprit has made a strong contribution since joining in September. He has quickly grasped our key business issues and has earned the confidence of our employees, leadership team and the board, positioning him well to take on the interim group MD role,” he added.

“Kelly has been leading the finance function since becoming group FD and is well known to Treatt’s investors from her IR role in recent years.

“We are confident that this new interim management structure, with Manprit working alongside our strong leadership team, will steward the business well until a new CEO is in place.”

As managing director, Randhawa will report to Treatt’s board, and will become a director of the company following a handover period with Shannon.

Randhawa has 20 years’ experience in finance, commercial operations and strategy, most recently at publicly traded life science company SkinBioTherapeutics.